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http://dx.doi.org/10.1016/j.jds.2012.1Abstract The objective of this study is to report the transformation of a 10-year history of
melanotic mandibular gingival lesion into primary oral melanoma (POM) in a 37-year-old Taiwa-
nese woman. The patient declined all treatments and died of widespread disease 15 months
after POM was confirmed. The histology of initial biopsies was totally benign, but the size of
lesion, irregular shape, and developing satellites of pigmentation at the periphery were clin-
ically atypical. However atypical it was, this clinical appearance was unknown to the
pathologists. This case demonstrates that oral melanoma can be preceded by a histologically
benign-appearing flat pigmented lesion for an extended time. Therefore, a benign oral
pigmentation should not be viewed as a harmless condition and regular periodical follow-up
is necessary. We argue that the diagnosis and risk assessment of oral pigmented lesions require
a team effort from both clinicians and pathologists to make an appropriate diagnosis and
achieve a favorable prognosis.
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Oral melanoma transformed from melanosis 329Introduction
Primary oral melanoma (POM) is extremely rare, accounting
for 0.5% of all oral malignancies and 0.2e8% of all mela-
nomas in Europe and the United States.1 The vast majority
(over 90%) of melanomas in the head and neck are cuta-
neous melanomas, followed by ocular and mucosal mela-
noma involving (in descending order of frequency) the
sinonasal cavity, oral cavity, pharynx, larynx, and esoph-
agus.1 Cutaneous melanoma is generally seen on the skin of
white people, whereas mucosal melanoma has been re-
ported as having a higher incidence in Indians (16%), Jap-
anese (11e14%), and Africans (4.6e8%) than in whites.1,2
Unlike the etiology of cutaneous melanoma that is linked
to sun exposure, the risk factors for oral melanomas remain
unknown. Tobacco use and chronic irritation may play some
role, but the evidence is weak.
POM can appear in any age group with a mean age of 56
years and a male preponderance. The most frequently
affectedoral sites are the palate andmaxillary gingiva. POM is
described as being preceded by a pre-existing oral pigmen-
tation 30e50% of the time1,2; moreover, few cases of POM
arising from benign melanosis and melanotic macules were
histologically documented.3e5 Small pigmented lesions with
an intact smooth mucosa can be confused easily with benign
conditions such as melanotic macules, melanoacanthoma,
melanocytic nevi, or smoker’s melanosis. The early radial
phases of oral melanoma usually develop slowly over years.
The finding that melanoma progresses from thin, radically
growing lesions to thick, vertical growing lesions suggests that
regression is associated with relatively early progression.
Thus, they can enlarge and bleed, and local or distant me-
tastases can occur until identification is completed.6,7 This
study demonstrates a case of POM with widespread metas-
tasis arising from a benign oral pigmentation.
Case presentation
In April 2002, a 28-year-old woman without any systemic
diseases or a history of melanoma, smoking, or alcohol
abuse presented with a thin melanotic mandibular gingival
lesion that had existed over 2 years. The lesion was initially
diagnosed histologically as a benign hyperpigmentation
(Fig. 1A), but it was clinically atypical and somewhat
worrisome because of its size, irregular shape, and the
feathering of the pigmentation at the periphery in the
labial and lingual gingiva of right mandibular teeth (Fig. 2A
and B). It was treated with CO2 laser, but recurred quickly.
The histology of second biopsies in December 2002 showed
benign gingival melanosis (Fig. 1B). Several attempts were
made to treat them with 755 nm Alexandra laser, 1064 nm
laser, and 532 nm laser in the department of dermatology
during the period of April 2003eAugust 2004, but the
therapeutic response was poor. Since there was no increase
in size or symptoms, she did not report for further treat-
ment until tumor hemorrhage and a palpable chin lymph-
adenopathy occurred in August of 2010. The patient
presented with an extensively growing melanotic lesion
over the entire mandibular gingiva, ranging from left canine
to right second molar, and extending to the lower lip,
buccal mucosa, and mouth floor with an obvious submentallymphadenopathy (Fig. 2C and D). The panoramic, peri-
apical radiograph and cone-beam computed tomography of
the mandible revealed severe osteolysis beneath the
tumor, especially around the incisors and symphyses area to
the inferior border of the mandible (Fig. 2G and H). The
third biopsy specimen showed plenty of atypical melano-
cyte hyperplasia with epithelium involvement consisting of
intraepithelial dispersion of neoplastic cells (Fig. 1C and D).
Further biopsy of a specimen from the submental mass
revealed a lymph node with effaced nodal architecture
replaced by neoplastic polygonal cells bearing vesicular
nuclei, prominent nucleoli, and abundant brownish black
pigments in the cytoplasm, which were proved by Fontana
Masson stain to be melanin pigments (Fig. 1EeH). The
neoplastic cells stained positive with S-100, HMB-45, and
CD117. The metastatic foci showed more pleomorphic cell
patterns than those seen in the primary sites, and meta-
static malignant melanoma was confirmed. The whole-body
positron emission tomography-computed tomography (PET-
CT) study detected increased fluorodeoxyglucose (FDG)
uptake and hypermetabolic lesions in the lower gum, lung,
liver, and pelvis, compatible with POM and malignancy
metastasis. An oncology group was consulted, but the pa-
tient declined all treatments.
During December 2010eFebruary 2011, notable areas
of depigmentation were found in the labial side of mobile
incisors (Fig. 2E and F), which were immobilized with
resin and wire. She continued her daily work without
complaints except for a body weight loss of 3 kg within
1 year. Thirteen months later, spontaneous exfoliation of
three mandibular incisors and left canine happened in
succession. Severe cough and indurate abdomen devel-
oped; chest radiograph showed bilateral pleural effusion
and multiple pulmonary nodules of variable sizes, sug-
gestive of tumor progression. The patient’s condition
rapidly deteriorated and she died of respiratory failure
and gastrointestinal bleeding 15 months after the diag-
nosis of POM.Discussion
A literature review supported that POM can be preceded,
for a variable period of time, by a flat pigmented lesion.1e6
The view of oral melanotic macule or melanosis considered
as an innocuous lesion without a malignant potential began
to change when few cases of the transformation of benign
oral pigmentation into POM were reported by Taylor and
Lewis in 1990,3 Kahn et al in 2005,4 and Kaehler et al in
2008.5 If so, should the melanin pigmentation of oral mu-
cosa be considered a premalignant lesion like leukoplakia?
What about oral melanosis that is frequently found in over
half of Negroes and in other colored races? However, there
have been no definite conclusion to date because of the
underexploration of the subject.
POM is rare, but pigmented entities are relatively
common in the oral mucosa with intrinsic and extrinsic
sources. The differential diagnoses should include mela-
notic macules, nevi, melanoacanthoma, smoker’s mela-
nosis, amalgam tattoo, racial pigmentation, vascular
blood-related pigments, and those related with sys-
temic diseases such as Addison disease and
Figure 1 (A) Histology of the first biopsies (in September 2002) demonstrating hyperpigmentation of the basal layer of squamous
epithelium, clusters of melanophages in the superficial stroma, elongated rete ridges without significant melanocytic activity, and
no atypical melanocytes. (B) The second biopsy (in December 2002) of the recurrent lesion exhibiting a benign gingival melanosis
with acanthosis, few brown pigments in the upper dermis, and chronic inflammatory cell infiltration. (C and D) The third biopsy (in
August 2011) demonstrating malignant melanoma with atypical hyperplasia of melanocytes with epithelium involvement consisting
of intraepithelial dispersion of neoplastic cells and existence of prominently pigment-laden atypical cells in the basal and sub-
mucosal area. (EeH) A biopsy of submental lymph node (in September 2011) demonstrating metastatic malignant melanoma with
effaced nodal architecture replaced by neoplastic polygonal cells bearing vesicular nuclei, prominent nucleoli, and abundant
melanin pigments in the cytoplasm. (G) The atypical melanocytes revealed strong cytoplasmic staining with Fontana Masson. (H)
Neoplastic cells were immunoreactive to S100 during immunohistochemical staining. Hematoxylineeosin stain: (AeC) 40, (D)
200, (E) 100, and (F) 400, Fontana Masson stain: (G) 400; S-100 stain: (H) 400.
330 S.-Y. Lu et alPeutzeJeghers syndrome.7 In other words, oral condi-
tions with increased melanin pigmentation are common,
but melanocytic hyperplasias are rare.4,7,8 Kahn et al4
suggested that melanocytic hyperplasia, even in the
absence of epithelial hyperplasia or dysplasia, might be
regarded as a sign of malignant change. Atypicalmelanocytes have been defined as melanocytes with
hyperchromatic and angular nuclei, but with infrequent
mitotic figures.4,8 A definitive precursor lesion for POM
has not been identified; however, atypical melanocytic
hyperplasia may represent a proliferative phase prior to
overt melanoma occurs.3e8
Figure 2 (A and B) Clinical appearance of a melanotic mandibular gingival lesion with atypical outline and feathering of the
pigmentation at the periphery (in April 2002). (C and D) Malignant melanoma with extensive growth over the entire mandibular
gingiva, lower lip, buccal mucosa, and mouth floor (in August 2010). (E) Melanoma with an area of hypopigmentation in the labial
gingiva of incisors (in December 2010). (F) Progressive melanoma with notable areas of depigmentation, resulting in mobile incisors
(in February 2011). (G and H) Periapical film and CBCT showing severe bone destruction and moth-eaten osteolysis around
mandibular incisors and the symphyses of mandible (in December 2010). CBCT Z cone-beam computed tomography.
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oral melanotic macule, labial lentigines, and racial pigmen-
tation, or vice versa, was not always easy because of the lack
of induration in thepigmented lesions, a small biopsy size, and
underdiagnosis of in situ lesions by both clinicians and pa-
thologists.6,7,9 The final diagnosis of POM must be confirmed
bypositive immunohistological staining for S100,Melan-A, and
HMB-45 or by cytoplasmic staining for Fontana Masson.1,6 Pri-
mary mucosal melanoma often exhibits a more aggressive
behavior than its cutaneous counterpart.1,2 Approximately a
third of patients have nodal involvement at presentation, andmost afflicted individuals harbor multiple micrometastases
prior to theclinicaldevelopmentofdistantdisease.1,7 Dentists
and patients should learn the so called “ABCDE checklist”
employed to identify cutaneous melanoma as the early
markers of oral malignant melanoma (OMM) transformation,
which includes the following: (A) asymmetry, (B) border ir-
regularity or bleeding, (C) color variegations or ulcer forma-
tion, (D) diameter enlargement, and (E) elevation, a raised
surface or erosion of bone. The histology of the first and sec-
ond biopsies in this case was totally benign, but the clinical
appearance was atypical because of the irregular periphery,
332 S.-Y. Lu et althe developing satellites, and a larger size than that is usually
associated with a melanotic macule. Therefore, a careful
assessment of the patient’s clinical appearance and histology
is necessary to make an appropriate diagnosis of oral pig-
mented lesions in its early in situ phase and achieve a favor-
able effect on prognosis.
Complete excision with adequate negative margins is
prioritized in the treatment of choice for POM. Unfortu-
nately, adequate local control is not a strong predictor for
survival.7 Many patients with a presumptive radical excision
of tumors develop a recurrence, which may be explained by
the presence of atypical melanocytes in the surgical mar-
gins or the presence of satellites and the concept of “field
cancerization” of POM.4,6 In addition, local failure may
indicate a risk of metastasis. The advances in chemo-
radiotherapy and immunotherapy have produced some
clinical response, but the conversion of transient remissions
to stable cures remains challenging.10 Therefore, the
prognosis of POM remains poor, and most patients died of
metastatic lesions, with an overall 5-year survival rate of
approximately 15% and a median survival rate of 18 months
after initial diagnosis.1,2,7
Laser technology is a medically acceptable method to
treat many cases with benign pigmented skin or oral le-
sions, but its therapeutic effect was poor in our case. Could
the laser therapy be a trigger factor for a benign melanotic
lesion to become malignant? There has been no evidence
on the issue to date to detect the relation of cause and
effect.
Benign oral melanotic lesions are generally considered
unlikely to become malignant, but our case demonstrates
that this might not be true. Therefore, periodical follow-ups of patients with benign oral pigmentation are
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